Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;13(5):e1702.
doi: 10.1002/wnan.1702. Epub 2021 Feb 3.

Cancer-associated-platelet-inspired nanomedicines for cancer therapy

Affiliations
Review

Cancer-associated-platelet-inspired nanomedicines for cancer therapy

Marzieh Geranpayehvaghei et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep.

Abstract

Platelets, with hemostasis and thrombosis activities, are one of the key components in the blood circulation. As a guard, they rapidly respond to any abnormal blood vessel injury signal and release their granules' contents, which induce their adhesion and aggregation on wound site for hemostasis. Recently, increasing evidence has indicated that platelets are critically involved in the growth and metastasis of cancer cells by releasing a variety of cytokines and chemokines to stimulate cancer cell proliferation and various angiogenic regulators to accelerate tumor angiogenesis. Platelets also secrete active transforming growth factor beta (TGF-β) to promote the epithelial-mesenchymal transition of cancer cells and their extravasation from primary site, and form microthrombus on the surface of cancer cells to protect them from immune attack and high-speed shear force in the circulation. Therefore, blocking platelet-cancer cell interaction may be an attractive strategy to treat primary tumor and/or prevent cancer metastasis. However, systemic inhibition or depletion of platelets brings risk of severe bleeding complication. Cancer-associated-platelets-targeted nanomedicines and biomimetic nanomedicines coated with platelet membrane can be used for targeted anticancer drug delivery, due to their natural targeting ability to tumor cells and platelets. In the current review, we first summarized the platelet mechanisms of action in physiological condition and their multiple roles in cancer progression and conventional antiplatelet therapeutics. We then highlighted the recent progress on the design and fabrication of cancer-associated-platelet-targeted nanomedicines and platelet membrane coating nanomedicines for cancer therapy. Finally, we discussed opportunities and challenges and offered our thoughts for the future development. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Biology-Inspired Nanomaterials > Lipid-Based Structures.

Keywords: cancer therapy; cancer-associated platelets; nanomedicines; platelet membrane coating nanomedicines.

PubMed Disclaimer

References

FURTHER READING
    1. Liu, Y., Luo, J., Chen, X., Liu, W., & Chen, T. (2019). Cell membrane coating technology: A promising strategy for biomedical applications. Nano-Micro Letters, 11(1), 100. https://doi.org/10.1007/s40820-019-0330-9
    1. Sevencan, C., McCoy, R. S. A., Ravisankar, P., Liu, M., Govindarajan, S., Zhu, J., & Leong, D. T. (2020). Cell membrane nanotherapeutics: From synthesis to applications emerging tools for personalized cancer therapy. Advanced Therapeutics, 3(3), 1900201.
REFERENCES
    1. Altinbas, M., Coskun, H., Er, O., Ozkan, M., Eser, B., Unal, A., Cetin, M., & Soyuer, S. (2004). A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. Journal of Thrombosis and Haemostasis, 2(8), 1266-1271.
    1. Andrews, R. K., Arthur, J. F., & Gardiner, E. E. (2014). Targeting GPVI as a novel antithrombotic strategy. Journal of Blood Medicine, 5, 59-68. https://doi.org/10.2147/JBM.S39220
    1. Anselmo, A. C., Modery-Pawlowski, C. L., Menegatti, S., Kumar, S., Vogus, D. R., Tian, L. L., & Mitragotri, S. (2014). Platelet-like nanoparticles: Mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano, 8(11), 11243-11253. https://doi.org/10.1021/nn503732
    1. Barthel, S. R., Gavino, J. D., Descheny, L., & Dimitroff, C. J. (2007). Targeting selectins and selectin ligands in inflammation and cancer. Expert Opinion on Therapeutic Targets, 11(11), 1473-1491. https://doi.org/10.1517/14728222.11.11.1473
    1. Bergmeier, W., & Hynes, R. O. (2012). Extracellular matrix proteins in hemostasis and thrombosis. Cold Spring Harbor Perspectives in Biology, 4(2), a005132. https://doi.org/10.1101/cshperspect.a005132

Publication types

Substances

LinkOut - more resources